Chiron, Roxane Settle Suit Over Tobramycin Patent

Law360, New York (October 14, 2003, 12:00 AM EDT) -- Biotech company Chiron Corporation and Children's Hospital and Regional Medical Center of Seattle have settled a patent infringement suit against Roxane Laboratories, a subsidiary of Boehringer-Ingelheim Corporation, Chiron said in a statement released Tuesday.

The suit concerned Roxane's plans to market a generic equivalent of TOBI tobramycin solution for inhalation, which has been patented by Chiron and Children's Hospital. TOBI has been approved by the FDA for cystic fibrosis (CF) patients with chronic pseudomonal lung infection. Cystic fibrosis (CF) is a genetic disease that primarily affects...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.